120MO Prognostic value of immune gene-expression signatures (iGES) vs tumor-infiltrating lymphocytes (TILs) in early-stage HER2+ breast cancer: A combined analysis of CALGB 40601 (C40601) and PAMELA trials

A. Fernandez-Martinez,T. Pascual, B. Singh, P. Nuciforo, K.A. Hoadley, N.U. Rashid,P.A. Spears, N. Chic, I. Krop, D. Hillman,A. Partridge,A. Prat,L.A. Carey,C.M. Perou

ANNALS OF ONCOLOGY(2021)

引用 2|浏览9
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要